Cencora (COR) Cash from Financing Activities (2009 - 2026)
Cencora (COR) reported Cash from Financing Activities of $4.0 billion for Q1 2026, up 909.08% on a YoY basis from $394.3 million in Q1 2025, and up 9108.79% quarter-over-quarter from $43.2 million in Q4 2025.
Cencora (COR) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Cencora has reported Cash from Financing Activities for 18 years, with the latest figure at $4.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 909.08% year-over-year to $4.0 billion; the trailing twelve-month figure through Mar 2026 stood at $3.6 billion (up 477.88% YoY), and the FY2025 full-year result was $2.2 billion, up 196.49% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $4.0 billion, up from $43.2 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $4.0 billion in Q1 2026, with the low at -$1.1 billion in Q2 2024.
- Historically, Cash from Financing Activities has averaged $4.2 million across 5 years, with a median of -$491.7 million in 2025.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities plunged 1298.79% — and 2026, when it surged 909.08%.
- Cencora's Cash from Financing Activities stood at -$963.9 million in 2022, then surged by 42.77% to -$551.7 million in 2023, then surged by 681.72% to $3.2 billion in 2024, then slumped by 98.65% to $43.2 million in 2025, then soared by 9108.79% to $4.0 billion in 2026.
- The last three Cash from Financing Activities figures came in at $4.0 billion (Q1 2026), $43.2 million (Q4 2025), and -$683.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.82 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 3.98 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -483.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 120.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 51.08 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.37 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 3.80 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 347,627.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.98 Bn |
| Mar 31, 2026 | 3.98 Bn |
| Dec 31, 2025 | 43.20 Mn |
| Dec 31, 2025 | 43.20 Mn |
| Sep 30, 2025 | -683.78 Mn |
| Sep 30, 2025 | -683.78 Mn |
| Jun 30, 2025 | 215.48 Mn |
| Jun 30, 2025 | 215.48 Mn |
| Mar 31, 2025 | -491.74 Mn |
| Mar 31, 2025 | -491.74 Mn |
| Dec 31, 2024 | 3.21 Bn |
| Dec 31, 2024 | 3.21 Bn |
| Sep 30, 2024 | -957.26 Mn |
| Sep 30, 2024 | -957.26 Mn |
| Jun 30, 2024 | -1.15 Bn |
| Jun 30, 2024 | -1.15 Bn |
| Mar 31, 2024 | 323.17 Mn |
| Mar 31, 2024 | 323.17 Mn |
| Dec 31, 2023 | -551.67 Mn |
| Dec 31, 2023 | -551.67 Mn |